Omics-informed drug target discovery in combating emerging infectious diseases

The catastrophic consequences of ever-increasing rates of death from infectious diseases demands new experimental strategies for drug target selection and drug design. Over the last decade, the pharmaceutical industry has been wounded by several issues including failure of drug-development programmes, burgeoning cost of drug development, increasing regulatory control, lack of innovation and declining productivity of therapeutic drugs in the market.

Read the full article @

https://www.drugtargetreview.com/article/37871/omics-informed-drug-target-discovery/